We leverage our co-founder’s medical and financial background to invest both long and short in biotechnology and pharmaceuticals.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 19, 2021
X4 Pharmaceuticals
|
Post-IPO Equity | $55M | Biotechnology | — |